FDA Crime Head To Depart Amid Misconduct Claims
Further details about Vermillion’s resignation weren’t immediately available. FDA representatives didn’t immediately respond to requests for comment Wednesday, and a call to the OCI wasn’t immediately returned.
"We appreciate Terry's years of public service and wish him well in retirement," FDA...
To view the full article, register now.